Jounce Therapeutics Number Of Shares Shorted vs. Price To Sales
| JNCEDelisted Stock | USD 1.88 0.00 0.00% |
For Jounce Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Jounce Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Jounce Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Jounce Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Jounce Therapeutics over time as well as its relative position and ranking within its peers.
Jounce |
Jounce Therapeutics Price To Sales vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Jounce Therapeutics's current stock value. Our valuation model uses many indicators to compare Jounce Therapeutics value to that of its competitors to determine the firm's financial worth. Jounce Therapeutics is rated third overall in number of shares shorted category among its peers. It is rated fourth overall in price to sales category among its peers . The ratio of Number Of Shares Shorted to Price To Sales for Jounce Therapeutics is about 277,614 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Jounce Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Jounce Price To Sales vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Jounce Therapeutics |
| = | 2.02 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Jounce Therapeutics |
| = | 7.27 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Jounce Price To Sales Comparison
Jounce Therapeutics is currently under evaluation in price to sales category among its peers.
Jounce Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Jounce Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Jounce Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Jounce Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Jounce Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. Jounce Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 137 people.
Jounce Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Jounce Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Jounce Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Jounce Therapeutics' important profitability drivers and their relationship over time.
Use Jounce Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jounce Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jounce Therapeutics will appreciate offsetting losses from the drop in the long position's value.Jounce Therapeutics Pair Trading
Jounce Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Jounce Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jounce Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jounce Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jounce Therapeutics to buy it.
The correlation of Jounce Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jounce Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jounce Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jounce Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Jounce Therapeutics position
In addition to having Jounce Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cash Cows Thematic Idea Now
Cash Cows
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Jounce Stock
If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |